tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Belite Bio TBA Spot Secondary; price range $150.00-$154.00
PremiumThe FlyBelite Bio TBA Spot Secondary; price range $150.00-$154.00
2d ago
Belite Bio Reports Increased Cash Reserves Amid Rising R&D Costs
Premium
Company Announcements
Belite Bio Reports Increased Cash Reserves Amid Rising R&D Costs
2d ago
Belite Bio Announces Public Offering of ADSs to Fund Expansion
Premium
Company Announcements
Belite Bio Announces Public Offering of ADSs to Fund Expansion
2d ago
Belite Bio Stock (BLTE) Jumps on Positive Phase 3 STGD1 Trial Data
PremiumMarket NewsBelite Bio Stock (BLTE) Jumps on Positive Phase 3 STGD1 Trial Data
3d ago
Belite Bio Reports Breakthrough Phase 3 Results for Stargardt Disease Treatment
Premium
Company Announcements
Belite Bio Reports Breakthrough Phase 3 Results for Stargardt Disease Treatment
3d ago
Belite Bio says tinlarebant met primary efficacy endpoint in Phase 3 trial
Premium
The Fly
Belite Bio says tinlarebant met primary efficacy endpoint in Phase 3 trial
3d ago
Belite Bio initiated with a Neutral at Mizuho
PremiumThe FlyBelite Bio initiated with a Neutral at Mizuho
14d ago
Promising Outlook for Belite Bio’s Tinlarebant Drives Buy Rating Amidst Strong Financial Position and Regulatory Support
Premium
Ratings
Promising Outlook for Belite Bio’s Tinlarebant Drives Buy Rating Amidst Strong Financial Position and Regulatory Support
22d ago
Belite Bio ADR’s Earnings Call: Progress Amid Rising Costs
Premium
Company Announcements
Belite Bio ADR’s Earnings Call: Progress Amid Rising Costs
22d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100